Previous research has showed that expression of STK11 was positively correlated with intertumoral infiltration of cluster of differentiation CD3+, CD4+, and CD8+ cells, demonstrating patients with high levels of STK11 would have better immune conditions for tumor control (27). The gene discussed is CD8A; the disease is neoplasm.